Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/23/2010EP1613348B1 Methods for modulating angiogenesis with apelin compositions
06/23/2010EP1608400B1 Elevation of adenosine level by cytokine-induced expression of cd73
06/23/2010EP1441747B1 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
06/23/2010EP1400550B1 Branched polyalkylene glycols
06/23/2010EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines
06/23/2010CN1898257B Methods for synthesis of encoded libraries
06/23/2010CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
06/23/2010CN1871351B Novel fungal proteins and nucleic acids encoding same
06/23/2010CN1871256B Muteins of tear lipocalin
06/23/2010CN1837237B Recombinant human interleukin1 receptor antagon (rhIL-1ra) with low pyrogen and its high efficiency preparation process
06/23/2010CN1809378B Methods for inhibiting viral replication in vivo
06/23/2010CN1777443B Methods of diagnosing and treating pre-eclampsia or eclampsia
06/23/2010CN1697648B Azithromycin dosage forms with reduced side effects
06/23/2010CN1620304B Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
06/23/2010CN1468108B Bone health compositions derived from milk
06/23/2010CN1446100B Method for treating movement disorder
06/23/2010CN101754974A Macrocyclic compounds as antiviral agents
06/23/2010CN101754769A The use of type-B lantibiotic-based compounds having antimicrobial activity
06/23/2010CN101754768A Survivin peptides as cancer vaccines
06/23/2010CN101754747A Methods and compositions for delivery of medicaments to the lungs
06/23/2010CN101754688A Glycated milk and uses thereof
06/23/2010CN101748180A Functional peanut small molecule mixed polypeptide, preparation method and application thereof
06/23/2010CN101748179A Preparation method of feather protein peptide
06/23/2010CN101748110A Desmoteplase alpha 1 mutant
06/23/2010CN101747440A TNFR-Fc fusion protein and usage thereof
06/23/2010CN101747437A Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein
06/23/2010CN101747430A Two peptides with oxidation resistant function - Fe-Alpha29 peptide-porphyrin iron and Beta13 peptide-porphyrin iron
06/23/2010CN101747424A Polypeptide for male immunocontraception
06/23/2010CN101747423A Centipede anti-tumor active protein
06/23/2010CN101747414A Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases
06/23/2010CN101747413A Envelope glycoprotein penetrating oligopeptide or modifier/ derivative thereof with blood platelet apoptosis activity inhibiting function and application
06/23/2010CN101747411A Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof
06/23/2010CN101747410A Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof
06/23/2010CN101747408A Technology for producing polypeptide-Fe through taking animal blood as raw material
06/23/2010CN101745118A Cell cytokine for treatment of Alzheimer
06/23/2010CN101745114A Method for preparing glucose-sensitive insulin controlled-release biological material
06/23/2010CN101745103A Normal-temperature preserved albumin preparation
06/23/2010CN101745102A Composition of 5-aminolevulinic acid and derivative thereof as well as application thereof
06/23/2010CN101745101A Skin external-use composition for promoting wound healing
06/23/2010CN101745100A Buccal insulin dropping pill and preparation method thereof
06/23/2010CN101745099A High-voltage electrostatic bur bract electric field foot patch for diabetes
06/23/2010CN101745098A Application of nerve polypeptide PACAP38 in the preparation of eye disease curing, injury repair or reproduction drugs
06/23/2010CN101745097A Alpha-conotoxins from Hainan province for specific blockage of acetylcholine receptor and application thereof
06/23/2010CN101745096A Combined medicament of brain protein hydrolysate
06/23/2010CN101745095A Composition of reduced glutathione and sodium carbonate or sodium bicarbonate
06/23/2010CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant
06/23/2010CN101744845A Chlorella extractive composition and preparation method thereof
06/23/2010CN101744768A Protein or nucleic acid drug liposome preparation and preparation method thereof based on tetraether lipid
06/23/2010CN101224298B Propofol compounds
06/23/2010CN101003569B Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application
06/22/2010US7741532 Diacylglycerol acyl transferase proteins
06/22/2010US7741468 protein hLRTM4 and the polynucleotide which encodes it; used to treat liver injury, hepatocellular carcinoma
06/22/2010US7741453 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability
06/22/2010US7741451 Antibodies that specifically bind hedgehog-derived polypeptides
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741440 Apoptin-associating protein
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741437 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
06/22/2010US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue
06/22/2010US7741435 Substance P-saporin (SP-SAP) conjugates and methods of use thereof
06/22/2010US7741434 High-affinity antagonists of ELR-CXC chemokines
06/22/2010US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
06/22/2010US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741310 A polynucleotide encodes an arginase, a nerve growth factors for treating nervous system disorders, neurodegenerative diseases
06/22/2010US7741308 DBAIT and uses thereof
06/22/2010US7741307 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2
06/22/2010US7741305 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease
06/22/2010US7741303 Stimulation of cellular regeneration and differentiation in the inner ear
06/22/2010US7741302 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids
06/22/2010US7741301 Transposase and method of gene modification
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741292 Method of inhibiting the emigration of cells from the intravascular compartment into tissues
06/22/2010US7741290 protein kinase C inhibitors (PKC); heart transplants
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/22/2010US7741288 serine/threonine phosphatases (PP1); immobilization, screening
06/22/2010US7741287 Peptides for the treatment of herpes virus infections
06/22/2010US7741286 kringle peptides; peptidase stabilized
06/22/2010US7741285 APO-2 ligand/trail formulations
06/22/2010US7741284 BMP10 propeptides and related methods
06/22/2010US7741283 transforming growth factor and insulin like growth factor binding protein 3 as ligands that engage low density lipoprotein receptor-related protein
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741281 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients
06/22/2010US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
06/22/2010US7741279 Modified pro-alpha chain of at least part of a secretory leukocyte protease inhibitor that is placed N-terminal to a triple helical forming domain of the pro-alpha chain; procollagen molecule; collagen matrix; treating chronic wounds and fibrotic disorders
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741277 reacting disorazole compound with a linkerto yield a mono- and/or bisfunctionalized disorazole-linker moiety, coupling mono- and/or bisfunctionalized disorazole-linker moiety with cell-binding molecules(peptide, protein, protein/peptide hormones, receptor ligand, blood plasma protein) to from conjugate
06/22/2010US7741276 Use of interleukin-18 inhibitors to inhibit tumor metastasis
06/22/2010US7741275 Short interfering RNA sequences specific for cathelicidin (cap18) gene for use in treatment and prevention of cell proliferative disorders
06/22/2010US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
06/22/2010US7741273 Drug dosage device designed for delivery of antiinflammatory or anabolic compounds to intervertebral discs or articulating joints, and for insertion of drug depots into discs or joint capsules with minimal tissue disruption and minimal interference with normal joint motion
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741269 Exendins and exendin agonists for weight reduction and obesity
06/22/2010US7741268 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741112 nucleic acid comprising a sequence encoding a mitochondrial localization signal from subunit VIII of human cytochrome oxidase operably linked to a sequence encoding a viral receptor
06/22/2010US7741111 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis
06/22/2010US7741090 Glucose dehydrogenase and process for producing the dehydrogenase
06/22/2010US7741085 Compound WS727713